KRISTI MORRIS: Open Payments
NPI 1104808005 · GARRETT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,414 in 86 payments from 23 companies in 2025. Trend: 2023 $1,746 · 2024 $2,196 · 2025 $1,414
Food & beverage: $1,414
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $262 |
| Sumitomo Pharma America, Inc. | 18 | $211 |
| ABBVIE INC. | 17 | $206 |
| PFIZER INC. | 9 | $146 |
| Lilly USA, LLC | 3 | $64 |
| Novo Nordisk Inc | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 3 | $60 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
Products named: GEMTESA, BREZTRI, VRAYLAR, JARDIANCE, PREVNAR 20, VOQUEZNA, NURTEC ODT, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
